Targeted Cancer Therapies: Innovative drugs and their impact on the future of oncology is a management report form Business Insights, this report assesses the role of targeted cancer therapies as a driver of growth in the cancer market and their future role potential. Drugs for high-severity conditions grew over the past decade at over twice the rate of drugs for low severity conditions, traditionally served by primary care blockbuster drugs. Increasingly, pharmaceutical companies are breaking into the cancer market through brands that are launched as a therapy for a minor indication and subsequently developed for other indications and first-in-line therapies. The new wave of innovation is being led by European companies and could bring about a revolution not only in cancer treatment, but across the industry as a whole.
This report provides detailed analysis of innovation in both the diagnosis and treatment of cancer and forecasts for the success of leading drugs, enabling your company to plan effective oncology strategies.
View Cart
